Table 1. Proportion of patients with haematological malignancies who took part in the 2010 NCPES (n=5925) who were alive in November 2011 and responded to the second survey.
|
Patents alive in November 2011 |
Responded to survey (n=200 per subtype) |
||||
|---|---|---|---|---|---|
| ICD-10 | Cancer type | N | (%) | N | (%) |
| C92.1 | Chronic myeloid leukaemia (CML) | 218 | (89.3) | 159 | (79.5) |
| C82-83 | Non-Hodgkin lymphoma (NHL) | 1730 | (87.5) | 161 | (80.9) |
| C91.1 | Chronic lymphocytic leukaemia (CLL) | 700 | (82.1) | 161 | (80.5) |
| C90 | Myeloma | 1695 | (78.8) | 150 | (76.1) |
| C91.0, C92.0 | Acute leukaemia | 477 | (68.1) | 154 | (80.2) |
| Total | 4820 | (81.4) | 785 | (79.4) | |